Ondine Biomedical Company Description

Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally.

Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections.

In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection.

Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada.

Ondine Biomedical Inc.

Country	Canada
Founded	1996
Industry	Biotechnology
Sector	Healthcare
Employees	18
CEO	Carolyn Cross

Contact Details

Address: 1100 Melville Street Vancouver, British Columbia V6E 4A6 Canada
Phone	604 669 0555
Website	ondinebio.com

Stock Details

Ticker Symbol	OBI
Exchange	London Stock Exchange AIM
Fiscal Year	January - December
Reporting Currency	CAD
ISIN Number	CA68234M2058
SIC Code	2834

Key Executives

Name	Position
Carolyn Cross	Chief Executive Officer
Alan Thomas	Chief Financial Officer